CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
The functional activity of the miR-1914-5p in lipid metabolism of the hepatocarcinoma cell line HepG2: a potential molecular tool for controlling hepatic cellular migration
Author
A LaganÃ
A Méndez-Lucas
+46Â more
AG Linden
APL Jensen-Urstad
B Marengo
BDO da Silva
BO de Silva
C Cheng
C Janani
C Le Sage
CM Silva
CN Brocker
D Buckley
D Sengupta
D Yang
E Currie
E Fischer
FJ Slack
G Medes
H-P Huai-Peng Lin
IIIa Pope
J Balogh
KK Sakane
KY Hsiao
L Opazo-RÃos
M Parmaksiz
MD Edmonds
ME Legrier
MN Protopapa
MR Zanotelli
MT Donato
N Okada
PC Sandoval
PI Escalante
R Mohr
R Rupaimoole
R Zheng
RJ Hamilton
S Lamouille
S Ye
SJR Steven
T Mosmann
TA Bowman
VA Stark
Y Jiang
Y Lapidot
YS Michaels
ZS Niu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Acute Coronary Syndromes: Risk Stratification and Initial Management
Author
Andersen
Antman
+49Â more
Antman
Antman
Boersma
Boersma
Braunwald
Braunwald
Budaj
Cannon
Cannon
CAPRIE Steering Committee
Christopher P. Cannon
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Fox
Fox
FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators
Goldman
Goldman
Goodman
Grines
Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico
Hamm
Heeschen
Hochman
Hochman
Keeley
Kontos
Lee
Morrow
Morrow
Neumann
Oler
Peters
Pope
Pozen
Sarasin
Scirica
Selker
Selker
Steinhubl
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators
The GUSTO IV-ACS Investigators
The Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The TIMI IIIA Investigators
Theroux
Tierney
TIMI Study Group
Widimsky
Yusuf
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref